Compare CWCO & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CWCO | CTKB |
|---|---|---|
| Founded | 1973 | 1990 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Water Supply | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 575.0M | 652.1M |
| IPO Year | N/A | 2021 |
| Metric | CWCO | CTKB |
|---|---|---|
| Price | $35.13 | $5.51 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 4 |
| Target Price | ★ $40.00 | $5.88 |
| AVG Volume (30 Days) | 71.5K | ★ 1.1M |
| Earning Date | 11-10-2025 | 02-26-2026 |
| Dividend Yield | ★ 1.57% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.05 | N/A |
| Revenue | $130,832,698.00 | ★ $196,828,000.00 |
| Revenue This Year | $4.65 | N/A |
| Revenue Next Year | $52.38 | $5.62 |
| P/E Ratio | $32.99 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $22.69 | $2.37 |
| 52 Week High | $38.36 | $7.30 |
| Indicator | CWCO | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 50.15 | 65.75 |
| Support Level | $34.37 | $4.90 |
| Resistance Level | $35.83 | $5.18 |
| Average True Range (ATR) | 0.72 | 0.21 |
| MACD | -0.10 | 0.05 |
| Stochastic Oscillator | 37.01 | 90.91 |
Consolidated Water Co Ltd is a water utility company. It develops and operates seawater desalination plants and water distribution systems. The company's business segments are; The retail segment operates the water utility for the Seven Mile Beach and West Bay areas of Grand Cayman Island, The bulk segment supplies potable water to government utilities in Grand Cayman and The Bahamas under long-term contracts, The services segment designs, constructs and sells water infrastructure and provides management and operating services to third parties. The manufacturing segment manufactures and services a wide range of custom and specialized water-related products applicable to commercial, municipal, and industrial water production, supply, and treatment, and the corporate segment.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.